Ghelfond has been acquired by NotreDame Intermédica
The owner of Ghelfond Group has sold the company to NotreDame Intermédica Group (GNDI).
Ghelfond Group is one of the biggest players in the imaging diagnostic services in the São Paulo region of Brazil, mostly targeting the lower income demand. With 11 patient service centers, the company has collection points for laboratory tests and performs tomography, radiology, mammography and bone densitometry exams, among others, in addition to 19 magnetic resonance and two radiotherapy machines for oncological treatment.
NotreDame Intermédica Group (GNDI) is one of Brazil’s largest healthcare operators, with nearly 6.3 million beneficiaries. It is recognized for its pioneering efforts in preventive medicine and for offering the best solutions in health and dental care. The company went public in 2018 and is listed on the Novo Mercado segment of the São Paulo Stock Exchange (B3) under the ticker GNDI3, and distributes quarterly dividends to shareholders. Founded in 1968 and headquartered in São Paulo, its service structure includes 28 hospitals, 88 clinics, 23 outpatient emergency rooms, 14 preventive care centers, 86 clinical analysis collection points, 12 imaging exam units and 2 health centers exclusively focused on the elderly “NotreLife 50+”. All are owned and managed by the group, located in the states of São Paulo, Rio de Janeiro, Minas Gerais, Paraná and Santa Catarina, in addition to a vast accredited network of health and dental clinics with 16,000 accredited dentists. Since 14 February 2022, GNDI has become a subsidiary of Hapvida Participações e Investimentos S.A. (B3: HAPV3).
One of Oaklins’ teams in Brazil acted as lead advisor to the seller and the management of Ghelfond in the preparation of the sale process and due diligence, the approach and parallel negotiations with potential buyers.
Talk to the deal team
Denis Salvador Morante
Oaklins Fortezza Partners
Related deals
Prestige Inhome Care has found a long-term strategic partner
Prestige Inhome Care has received a growth capital investment from Yorkway Private. The newly formed partnership will provide growth capital for geographic expansion, increasing Prestige’s range of services and potential future acquisitions. The investment in Prestige is in line with Yorkway’s mandate to invest in leading Australian mid-market companies with strong management teams, backed by significant growth tail winds, as is the case in the aged care industry.
Learn moreCara Care has been acquired by Mahana Therapeutics
Mahana Therapeutics Inc., renowned for its pioneering digital treatments targeting chronic health issues, has recently finalized the acquisition of Cara Care (HiDoc Technologies GmbH). Cara Care stands out as a premier digital health platform and an official digital health application (DiGA) dedicated to enhancing gut health. This acquisition, supported by key investors Lux Capital and Jazz Ventures Partners, perfectly aligns with Mahana’s expansion strategy.
Learn moreApotheka acquires two pharmacy outlets from Panpharmacy
In a strategic move that signifies the ongoing consolidation and growth within the Latvian pharmaceutical retail sector, Panpharmacy, the parent company of the leading online pharmacy InternetAptieka.lv, has successfully completed the sale of two of its brick-and-mortar pharmacies to Apotheka. These pharmacies, both situated in the capital city of Riga, will continue to serve customers under the Apotheka brand, marking a seamless transition in ownership and operations.
Learn more